Wall Street Teams With BlackRock to Provide Bond Price Data
  • November 18, 2024

Wall Street Teams With BlackRock to Provide Bond Price Data

(Bloomberg) -- Some of Wall Street’s biggest banks are teaming up with BlackRock Inc.’s Aladdin technology system to provide real-time pricing data for trading US corporate bonds – still one of the most opaque areas in financial markets.Most Read from BloombergIn Cleveland, a Forgotten Streetcar Bridge Gets a Long-Awaited LiftParis to Replace Parking Spaces With TreesAmtrak Wins $300 Million to Fix Its Unreliable NJ-to-NYC ServiceA Bug’s Eye View of Mexico City’s Modernist ArchitectureNew York’s

Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps
  • November 18, 2024

Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps

On Monday, Twist Bioscience Corporation (NASDAQ:TWST) reported a fourth-quarter loss per share of 59 cents, beating the consensus loss of 70 cents. Twist Bioscience reported fourth-quarter sales of $84.71 million, up 27% year-over-year, beating the consensus of $82.2 million and the management guidance of $82 million–$83 million. The company shipped products to approximately 3,562 customers in fiscal 2024, compared to approximately 3,450 in 2023. Twist shipped approximately 772,000 genes in 2024

Kevin O'Leary: 'Biden-Harris Regulations Held Back Energy, But Markets Now Celebrate Expansion'
  • November 18, 2024

Kevin O'Leary: 'Biden-Harris Regulations Held Back Energy, But Markets Now Celebrate Expansion'

Kevin O’Leary recently appeared on The Daniela Cambone Show, where he discussed the current state of the U.S. energy sector and broader market trends. O’Leary, known for his outspoken views on business and investment, shared his thoughts on how regulatory changes under the Biden-Harris administration have impacted the economy, particularly in energy and how markets are reacting now. Don't Miss: With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has sk

Why Is Penny Stock HCW Biologics Surging On Monday?
  • November 18, 2024

Why Is Penny Stock HCW Biologics Surging On Monday?

HCW Biologics Inc (NASDAQ:HCWB) stock is trading higher during Monday premarket with a strong session volume of 10.03 million versus an average volume of 48.02K, as per data from Benzinga Pro. HCW Biologics and WY Biotech Co., Ltd., a China-based company specializing in the early-stage development of recombinant protein drugs and gene/cell therapies, have entered into a worldwide exclusive license agreement. The agreement covers the development and commercialization of one of HCW Biologics’ prod